Nick Houtman

Corvallis Science Pub focuses on Ebola‏

CORVALLIS, Ore. – As deaths from the latest Ebola outbreak mount, health care providers continue to search for effective treatments. One promising approach has been developed by a Corvallis company, Sarepta Therapeutics (formerly AVI Biopharma).

Subscribe to Nick Houtman